160 related articles for article (PubMed ID: 32691143)
1. ANCA-associated pauci-immune necrotizing glomerulonephritis during the treatment with pembrolizumab.
Uner M; Alhasson B; Obhrai J; Bagnasco SM
Virchows Arch; 2021 Apr; 478(4):801-804. PubMed ID: 32691143
[TBL] [Abstract][Full Text] [Related]
2. Renal Vasculitis and Pauci-immune Glomerulonephritis Associated With Immune Checkpoint Inhibitors.
Gallan AJ; Alexander E; Reid P; Kutuby F; Chang A; Henriksen KJ
Am J Kidney Dis; 2019 Dec; 74(6):853-856. PubMed ID: 31204194
[TBL] [Abstract][Full Text] [Related]
3. Renal Effects after Pembrolizumab Treatment for Non-small Cell Lung Carcinoma.
Oki R; Hirakawa Y; Kimura H; Honda K; Hinata M; Abe H; Domoto Y; Tanaka G; Nagase T; Nangaku M
Intern Med; 2020 Apr; 59(7):977-981. PubMed ID: 31813918
[TBL] [Abstract][Full Text] [Related]
4. [Rapidly progressive ANCA positive glomerulonephritis as the presenting feature of infectious endocarditis].
Hanf W; Serre JE; Salmon JH; Fabien N; Ginon I; Dijoud F; Trolliet P
Rev Med Interne; 2011 Dec; 32(12):e116-8. PubMed ID: 21277658
[TBL] [Abstract][Full Text] [Related]
5. Pembrolizumab-induced mucositis in a patient with recurrent hypopharynx squamous cell cancer.
Pelster MS; Mott F; Lewin J
Laryngoscope; 2020 Apr; 130(4):E140-E143. PubMed ID: 31074845
[TBL] [Abstract][Full Text] [Related]
6. Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis.
Lionaki S; Jennette JC; Falk RJ
Semin Immunopathol; 2007 Nov; 29(4):459-74. PubMed ID: 17943286
[TBL] [Abstract][Full Text] [Related]
7. IgA nephropathy after pembrolizumab therapy for mesothelioma.
Wang R; Das T; Takou A
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33257374
[TBL] [Abstract][Full Text] [Related]
8. Development of pauci-immune necrotizing glomerulonephritis during pembrolizumab treatment.
Matsumoto J; Saka Y; Naruse T
Clin Exp Nephrol; 2024 Feb; 28(2):177-178. PubMed ID: 37847435
[No Abstract] [Full Text] [Related]
9. ANCA-positive crescentic glomerulonephritis associated with minocycline therapy.
Sethi S; Sahani M; Oei LS
Am J Kidney Dis; 2003 Aug; 42(2):E27-31. PubMed ID: 12900849
[TBL] [Abstract][Full Text] [Related]
10. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases.
Haas M; Eustace JA
Kidney Int; 2004 Jun; 65(6):2145-52. PubMed ID: 15149327
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic autoantibody-negative Pauci-immune crescentic glomerulonephritis.
Chen M; Yu F; Wang SX; Zou WZ; Zhao MH; Wang HY
J Am Soc Nephrol; 2007 Feb; 18(2):599-605. PubMed ID: 17215440
[TBL] [Abstract][Full Text] [Related]
12. Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab.
Acero Brand FZ; Suter N; Adam JP; Faulques B; Maietta A; Soulières D; Blais N
J Immunother Cancer; 2018 Mar; 6(1):22. PubMed ID: 29548299
[TBL] [Abstract][Full Text] [Related]
13. Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report.
Manabe S; Hatano M; Nakano M; Fujii T; Nitta K; Nagata M
Pathol Int; 2017 Aug; 67(8):419-424. PubMed ID: 28580649
[TBL] [Abstract][Full Text] [Related]
14. Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis.
Villacorta J; Diaz-Crespo F; Acevedo M; Guerrero C; Mollejo M; Fernandez-Juarez G
Nephrology (Carlton); 2016 Apr; 21(4):301-7. PubMed ID: 26369898
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibody-negative pauci-immune crescentic glomerulonephritis associated with rheumatoid arthritis: An unusual case report.
Hsieh HS; Chang CF; Yang AH; Kuo HL; Yang WC; Lin CC
Nephrology (Carlton); 2003 Oct; 8(5):243-7. PubMed ID: 15012711
[TBL] [Abstract][Full Text] [Related]
16. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters?
Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M
Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223
[TBL] [Abstract][Full Text] [Related]
17. MPO-ANCA-positive crescentic necrotizing glomerulonephritis and tubulointerstitial nephritis with renal eosinophilic infiltration and peripheral blood eosinophilia.
Yamamoto T; Yoshihara S; Suzuki H; Nagase M; Oka M; Hishida A
Am J Kidney Dis; 1998 Jun; 31(6):1032-7. PubMed ID: 9631850
[TBL] [Abstract][Full Text] [Related]
18. Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients.
Rogado J; Sánchez-Torres JM; Romero-Laorden N; Ballesteros AI; Pacheco-Barcia V; Ramos-Leví A; Arranz R; Lorenzo A; Gullón P; Donnay O; Adrados M; Costas P; Aspa J; Alfranca A; Mondéjar R; Colomer R
Eur J Cancer; 2019 Mar; 109():21-27. PubMed ID: 30682533
[TBL] [Abstract][Full Text] [Related]
19. Pauci-immune necrotizing glomerulonephritis complicating rheumatoid arthritis.
Qarni MU; Kohan DE
Clin Nephrol; 2000 Jul; 54(1):54-8. PubMed ID: 10939757
[TBL] [Abstract][Full Text] [Related]
20. Renal histology in pauci-immune rapidly progressive glomerulonephritis: 8-year retrospective study.
Minz RW; Chhabra S; Joshi K; Rani L; Sharma N; Sakhuja V; Duggal R; Pasricha N
Indian J Pathol Microbiol; 2012; 55(1):28-32. PubMed ID: 22499296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
